nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma
|
Dowell, Jonathan E. |
|
2012 |
77 |
3 |
p. 567-571 5 p. |
artikel |
2 |
Beliefs and attitudes about lung cancer screening among smokers
|
Jonnalagadda, Sirisha |
|
2012 |
77 |
3 |
p. 526-531 6 p. |
artikel |
3 |
Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: A randomized, phase-II study
|
Kusagaya, Hideki |
|
2012 |
77 |
3 |
p. 550-555 6 p. |
artikel |
4 |
Blinded and uniform cause of death verification in a lung cancer CT screening trial
|
Horeweg, N. |
|
2012 |
77 |
3 |
p. 522-525 4 p. |
artikel |
5 |
Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy
|
Kim, Seok-Hyun |
|
2012 |
77 |
3 |
p. 578-584 7 p. |
artikel |
6 |
Clinicopathological characteristics of subcentimeter adenocarcinomas of the lung
|
Kato, Fumiaki |
|
2012 |
77 |
3 |
p. 495-500 6 p. |
artikel |
7 |
Contents
|
|
|
2012 |
77 |
3 |
p. vii-viii nvt p. |
artikel |
8 |
Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: Review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype
|
da Cunha Santos, Gilda |
|
2012 |
77 |
3 |
p. 501-506 6 p. |
artikel |
9 |
Editorial Board
|
|
|
2012 |
77 |
3 |
p. v- 1 p. |
artikel |
10 |
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
|
Park, S.J. |
|
2012 |
77 |
3 |
p. 556-560 5 p. |
artikel |
11 |
Estimating typical, best-case and worst-case life expectancy scenarios for patients starting chemotherapy for advanced non-small-cell lung cancer: A systematic review of contemporary randomized trials
|
Kiely, B.E. |
|
2012 |
77 |
3 |
p. 537-544 8 p. |
artikel |
12 |
Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer
|
Hu, Jing |
|
2012 |
77 |
3 |
p. 593-599 7 p. |
artikel |
13 |
Final results and pharmacoeconomic analysis of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomised study by the European Lung Cancer Working Party
|
Berghmans, T. |
|
2012 |
77 |
3 |
p. 605-610 6 p. |
artikel |
14 |
HER family receptor and ligand status in thymic carcinoma
|
Weissferdt, Annikka |
|
2012 |
77 |
3 |
p. 515-521 7 p. |
artikel |
15 |
Intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines
|
Ryu, Seung-Hee |
|
2012 |
77 |
3 |
p. 482-487 6 p. |
artikel |
16 |
Issues surrounding clinical trial endpoints in solid malignancies with a focus on metastatic non-small cell lung cancer
|
Garon, Edward B. |
|
2012 |
77 |
3 |
p. 475-481 7 p. |
artikel |
17 |
miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1
|
Zhang, Xuelin |
|
2012 |
77 |
3 |
p. 488-494 7 p. |
artikel |
18 |
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET
|
Scheffler, Matthias |
|
2012 |
77 |
3 |
p. 617-620 4 p. |
artikel |
19 |
Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene
|
Pelosi, Giuseppe |
|
2012 |
77 |
3 |
p. 507-514 8 p. |
artikel |
20 |
Outcomes of elderly patients with stage IIIB–IV non-small cell lung cancer admitted to the intensive care unit
|
Bonomi, Marcelo R. |
|
2012 |
77 |
3 |
p. 600-604 5 p. |
artikel |
21 |
Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer
|
Lo, Fang-Yi |
|
2012 |
77 |
3 |
p. 585-592 8 p. |
artikel |
22 |
Physical activity level and quality of life in long term lung cancer survivors
|
Solberg Nes, Lise |
|
2012 |
77 |
3 |
p. 611-616 6 p. |
artikel |
23 |
Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis
|
Bae, Hyun-Mi |
|
2012 |
77 |
3 |
p. 572-577 6 p. |
artikel |
24 |
Prophylactic cranial irradiation in patients with small cell lung cancer. A retrospective study of recurrence, survival and morbidity
|
Ramlov, A. |
|
2012 |
77 |
3 |
p. 561-566 6 p. |
artikel |
25 |
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer
|
Price, Allan |
|
2012 |
77 |
3 |
p. 532-536 5 p. |
artikel |
26 |
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy
|
Salloum, Ramzi G. |
|
2012 |
77 |
3 |
p. 545-549 5 p. |
artikel |